Back to Emergency Medicine
Emergency Medicinev2019Evidence-Based

ROX Index for Intubation after HFNC

Predicts high-flow nasal cannula (HFNC) failure and need for intubation in patients with acute hypoxemic respiratory failure. The ROX Index combines oxygen saturation, fraction of inspired oxygen, and respiratory rate to provide early prediction of treatment success or failure, helping clinicians make timely decisions about escalation of care to avoid delayed intubation and associated complications.

Clinical Input Parameters

%
Range: 70 — 100 %
fraction
Range: 0.21 — 1 fraction
breaths/min
Range: 10 — 50 breaths/min
Clinical Assessment
Awaiting Parameters
rox index value
—index
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The ROX Index for Intubation after HFNC is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within emergency medicine.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

ROX Index = (SpO2/FiO2 × 100) / Respiratory Rate, where SpO2 is oxygen saturation (%), FiO2 is fraction of inspired oxygen (0.21-1.0), and Respiratory Rate is breaths per minute

Clinical Pearls & Practice Notes

  • ROX Index predicts HFNC failure and need for intubation in acute hypoxemic respiratory failure
  • Measure at 2, 6, and 12 hours after HFNC initiation for optimal prediction accuracy
  • Higher ROX index values indicate better prognosis and lower intubation risk
  • ROX ≥4.88 associated with >80% positive predictive value for HFNC success
  • ROX <3.85 has 98-99% specificity for predicting HFNC failure when measured <12 hours
  • Serial measurements more valuable than single time point assessment
  • Never delay intubation when clinical signs indicate respiratory decompensation
  • Modified ROX-HR index (ROX/heart rate × 100) may provide enhanced early prediction
  • Validated in multiple patient populations including COVID-19, pneumonia, and ARDS
  • Performance may vary in immunocompromised patients
  • Should be used in conjunction with clinical assessment and other markers
  • Cutoff values may vary by timing: 2.85 at 2 hours, 3.47 at 6 hours, 3.85 at 12 hours
  • Meta-analysis shows pooled sensitivity 67% and specificity 72% for HFNC failure prediction
  • Prediction accuracy improves over time with highest AUC at 12 hours
  • Optimal confidence interval for HFNC outcome prediction: 4.2-5.4
  • Simple bedside tool requiring only SpO2, FiO2, and respiratory rate
  • Cost-effective method for risk stratification in respiratory support decisions
  • May help reduce delayed intubation and associated complications
  • Useful for resource allocation and clinical decision-making in intensive care
  • Consider trending values rather than relying on single measurement

Evidence & Literature Citations

  1. Roca O, Messika J, Caralt B, García-de-Acilu M, Sztrymf B, Ricard JD, Masclans JR. Predicting success of high-flow nasal cannula in pneumonia patients with hypoxemic respiratory failure: The utility of the ROX index. J Crit Care. 2016 Oct;35:200-5. doi: 10.1016/j.jcrc.2016.05.022.
  2. Roca O, Caralt B, Messika J, Samper M, Sztrymf B, Hernández G, García-de-Acilu M, Frat JP, Masclans JR, Ricard JD. An Index Combining Respiratory Rate and Oxygenation to Predict Outcome of Nasal High-Flow Therapy. Am J Respir Crit Care Med. 2019 Jun 1;199(11):1368-1376. doi: 10.1164/rccm.201803-0589OC.
  3. Suliman LA, Abdelgawad TT, Farrag NS, Abdelwahab HW. Validity of ROX index in prediction of risk of intubation in patients with COVID-19 pneumonia. Adv Respir Med. 2021;89(1):1-6. doi: 10.5603/ARM.a2020.0176.

Score Interpretation Ranges

High Risk for HFNC Failure0 – 3.84 pts

Early intubation consideration

Indeterminate Risk3.85 – 4.87 pts

Reassess in 1-2 hours

Lower Risk for Intubation4.88 – 20 pts

Continue HFNC and wean FiO2

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.